13F-HR/A filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR/A for the quarter ended 2024-06-30, filed 2024-08-27, with 57 holding rows worth $1,243,285,030.
- Accession
- 0001172661-24-003755
- Filer
- CIK 1792126
- Filed
- 2024-08-27
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, amendment of type new holdings, 57 entries on the cover page, a total value of $1,243,285,030 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,243,285,030 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 2,000,000 | $185,420,000 | dollars as filed | put |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 500,000 | $79,000,000 | dollars as filed | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 2,000,000 | $76,720,000 | dollars as filed | call |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,700,000 | $59,687,000 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 135,000 | $58,055,400 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 850,000 | $50,294,500 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,200,000 | $46,572,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,100,000 | $43,197,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 925,000 | $41,689,750 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 5,150,000 | $35,226,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,208,875 | $34,720,028 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 950,000 | $34,371,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 750,000 | $32,977,500 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 750,000 | $31,417,500 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,500,000 | $28,395,000 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,476,061 | $28,045,159 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 150,000 | $23,700,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 800,000 | $18,768,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 450,000 | $17,671,500 | dollars as filed | call |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 5,032,501 | $16,858,878 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 3,300,000 | $16,170,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 400,000 | $15,344,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 575,000 | $15,180,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 195,000 | $14,792,700 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 375,000 | $14,621,250 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 300,000 | $14,298,000 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,050,000 | $14,185,500 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 5,900,000 | $13,924,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 595,000 | $13,905,150 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 575,000 | $13,518,250 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 1,200,000 | $11,316,000 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 40,000,000 | $10,840,000 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 1,301,518 | $10,425,159 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 3,850,000 | $10,395,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 265,000 | $9,351,850 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,500,000 | $9,300,000 | dollars as filed | call |
| BIOHAVEN LTD | G1110E107 | COM | 250,000 | $8,677,500 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,300,000 | $8,476,000 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 2,800,000 | $8,344,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 350,000 | $7,535,500 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 1,500,000 | $7,350,000 | dollars as filed | call |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,159,030 | $7,000,541 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 539,079 | $6,722,315 | dollars as filed | |
| LINEAGE CELL THERAPEUTICS IN | 53566P109 | COMMON STOCK | 4,700,000 | $4,687,310 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 3,000,000 | $4,680,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 500,000 | $4,550,000 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 208,910 | $4,373,322 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 2,500,000 | $3,975,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 300,000 | $2,949,000 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,900,000 | $2,900,000 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 416,666 | $2,858,329 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 600,000 | $2,661,900 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 90,000 | $2,430,900 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 3,469,927 | $1,738,780 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 493,827 | $577,778 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 117,806 | $433,114 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $10,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-003502 | superseded | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001172661-24-003755 | this filing | 2024-08-27 | acceptance time not in the bulk data set |